Skip to main content

Pharmacy

By Jeff Lagasse | 10:37 am | November 09, 2023
This could also improve outcomes for racial and ethnic minority groups, who generally have higher rates of hypertension.
By Jeff Lagasse | 03:14 pm | November 03, 2023
Premier and the American Hospital Association laud a recent Supreme Court decision but say HHS is still acting unlawfully.
By Jeff Lagasse | 10:38 am | November 01, 2023
Nostrum admitted it acquired Nitro OS from another manufacturer and continued to market it based on its preexisting FDA approval.
By Susan Morse | 11:05 am | October 19, 2023
Cloud platform JUDI drives savings for plan sponsors by providing patients with the lowest available drug prices, company says. 
By Jeff Lagasse | 11:15 am | October 18, 2023
HHS wants to ensure affordable access for beneficiaries in public programs such as Medicare and Medicaid, and for the uninsured.
By Susan Morse | 09:54 am | October 03, 2023
The drugs selected account for $50.5 billion in Part D gross covered prescription drug costs, or about 20% of the total, CMS says.
By Susan Morse | 11:26 am | October 02, 2023
Drug manufacturers must now enter into an agreement with HHS to take part in the price negotiation process. 
By Jeff Lagasse | 11:05 am | September 25, 2023
The benefits of ketamine, the company says, include interrupting unhealthy thought patterns and increasing neuroplasticity.
By Jeff Lagasse | 03:59 pm | September 21, 2023
The program allows members to save on 50+ generic medications that are typically used by consumers with a discount card.
By Jeff Lagasse | 11:29 am | September 20, 2023
The partnership grew out of a philosophical alignment between the companies, with each citing the desire to simplify access and pricing.